# Antihistamines in Eosinophilic Esophagitis

> **NCT04248712** · PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 1 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Famotidine
- **DRUG:** Loratadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04248712
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-10
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04248712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04248712, "Antihistamines in Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04248712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*